Nasopharyngeal carcinoma

  • View

  • Download

Embed Size (px)


Nasopharyngeal carcinoma. ABU SUFIAN HASSAN AHMED EL HAJ (E.N.T. Consultant) Associate Professor Department of Surgery Faculty of Medicine, University of Gezira. ANATOMY. ANATOMY. Introduction. - PowerPoint PPT Presentation

Text of Nasopharyngeal carcinoma

  • Nasopharyngeal carcinoma


    Associate Professor Department of SurgeryFaculty of Medicine, University of Gezira



  • Introduction The Nasopharynx has a cuboidal shape, the lateral walls are formed by the Eustachian tube and the fosse of Rosenmuller.The roof, sloping downwards from the anterior to posterior, is boarder by pharyngeal Hypopharyx, pharyngeal tonsil, and pharyngeal bursa with the base of skull above.

  • Anteriorly, the Nasopharynx abutted the choanae and nasal cavity, posterior boundary is formed by the muscle of posterior pharyngeal wall. Inferiorly, the Nasopharynx ends at an imaginary horizontal line formed by the upper surface of the soft palate and the posterior pharyngeal wall.

  • Pathology of the Nose and Nasopharynx1. Congenital malformations.2. Inflammation.3. Infection and Granulomatus Diseases4. Trauma.5. neoplasm

  • 1- Congenital malformations 1.Choanal stenosis or atresia.2.Involvmemt in cleft palate.3.Saddle nose in hypertelorism.

  • 1.Choanal stenosis or atresia.

  • 2. Inflammations & Infections.A. Acute Rhinitis or Rhino sinusitis B. Chronic Rhinitis or Rhino sinusitis - Nonspecific, - Specific

  • Cont.A. Acute Rhinitis or Rhino sinusitis Inflammation of the nasal mucosa with or with out Inflammation of the PNS mucosa due to: (i) Allergy (ii) Viral infection (iii) Bacterial infection

  • Cont.B. Chronic Rhinitis or Rhino- sinusitis: i- Chronic Non specific infection as, Bacterial infection

  • ii- Chronic specific infection as, 1- Tuberculosis 2- Leprosy 3- Scleroma 4- Fungal infections as, * Aspergillosis * Rhinosporidiosis * Candidiasis 5- Leishmaniasis

  • Nasal polyposis a. Allergic i- Allergic rhinitis ii- Vasomotor rhinitis * bilaterally * ethimoids * associated ;Asthma, penicillin& aspirin allergy.

  • Cont. nasal polpsNon allergic including antro-choanal polps

  • 4. Trauma.

  • 5.NeoplasmBenign tumors Malignant tumors

  • Benign tumors 1-Epithelial i- Papilloma : HPV , EBV a- Squamous ,fungiform : wart , in vestibule & septum. b- Inverted Papilloma (Tansitional) lateral wall , high recurrence , 10% malignant transformation (intermediate tumour)

  • Benign tumors 1-Epithelial Cont. c- Keratoacanthoma. (exposed skin to sun ___scc)d- Adenoma ( mucous glands).

  • Malignant tumors Epithelial Carcinoma a. Scc b. Tansitional type c. Adenocarcinama d. AnaplasticMalignant Melanoma

  • 2- Vascular Benign tumors a. Capillary haemangioma b. Juvenile angiofibroma c. Haemangiopericytoma (intermediate tumour) Malignant tumors Haemangiopendothelioma(Angiosarcom)

  • 3- Lymphoid tissue i- Lymphoma II- Myeloma

  • 4- Neurogenici.Neurofibroma II. Nasal glioma (ectopic glial tissue) iii. Olfactory neuroblastomiv. Neurilemmoma (schwannoma) nerve sheath-

  • 5- Bone and connective tissuesBenign tumors a. Osteoma b. Chondroma c. Ossifying fibroma Malignant tumors a. Fibrosarcoma b.Chondrosarcoma c. Osteogenic sarcoma

  • Tumours of the Nasopharynx Benign tumors a. Tansitional type papilloma b. Adenoma c. Cavernus haemangioma d. Juvenile angiofibroma

  • Malignant tumors 1-Carcinomas a. Anaplastic carcinoma including (lymphoepitheoma) b. Squamous cell carcinoma c. Tansitional type carcinoma d. Adenocarcinama.

  • Malignant tumors NPx2-Lymphoma and Myeloma 3-Sarcomas a.Rhabdomyosarcoma b. Fibrosarcoma c. Chondrosarcoma4- Chondroma arising from the base of skull

  • Nasopharyngeal carcinoma (NPC) is epidemiologically and histologically different from other head and neck cancers5

  • . It is an, Epstein-Barr Virus (EBV)associated carcinoma. It has been demonstrated that EBV is harbored in almost every NPC tumor, regardless of the degree of differentiation and geographic distribution.2, 3, 4,5

  • NPC highest incidence in the World is in Southeast China, Hong Kong and Mediterranean basin.

  • North Africa and Mediterranean basin. It commonly has poorly differentiated or undifferentiated pathology with a high incidence of cervical lymph node metastasis and great radiosensitivity and chemosensitivity1

  • Age distribution ranged from 11 to 82 years with mean age 44.25 years and median of 46 years. The male to female ratio was 2:1.

  • Table (2): Types of malignancies encountered at INMO.

    No.TypeFrequencyPercentage1Hematology63323.82Breast50118.83GIT36713.84Head and neck31411.85Gynecology31011.66Urology22208.37Childhood tumors09303.58Soft tissue sarcoma08103.09Bone tumors06602.510Skin04701.811Others brain ,lung)2801.1Total2662100%

  • Graph 1: Sex distribution33.3%Female66.7%MALE

  • On the other hand it has low incidence in Europe, Japan and North America.(JCO, Abdelrahhim). Most cases presents with local disease and cervical lymphadenopathy.

  • Nasopharyngeal cancer (NPC) is a common cancer in Sudanese and affects men more than women.

  • Sudanese usually presents late with cervical lymphadenopathy.

    The commonest histological types were

    WHO type II and III.


  • NPC characterize by non-specific presentation. Most cases presents with local disease and/or cervical lymphadenopathy, approximately 60-90% of patients present with cervical nodal metastasis3, 11, 12, 13. Patients with nodal metastasis have, higher rates of treatment failure

  • Symptoms related to primary tumor include ear pain, nasal tone speech, hearing loss, trismus and symptoms and signs of other cranial nerves involvement 14. Larger tumors may cause nasal block and bleeding. In Sudan NPC is the leading cancer in men15.

  • CLINICAL PRESENTATIONS The patients had different clinical presentationsThe most common clinical presentation in the order of frequency was Cervical lymphadenopathy(73.2%).Nasal block(33.9%).Hearing impairment(27.7%).Epistaxis(22.3%). Ear pain(18.8%). Palatal paralysis(14.3%).

  • 1- NECK MASS Cervical lymph nodes - More than 75% - unilateral or bilateral - Jugulodigastic L N

  • 2. NASAL. > 40% Of patients may presented with Nasal symptoms, in the forms of: - Nasal bleeding - Nasal mass. - Nasal discharge.. - Nasal deformity - Nasal obstruction.

  • 3- EAR > 30% Of patients may presented with otological symptoms, Include - Ear pain, - Hearing loss, - Ear discharge ( Secrotory otitis media) Eustachian tube obstruction


  • Table (1) : Cranial nerve injury

    NoNerveNo. of patientsPercent %1Optic 010.892Occulomotor076.253Trigeminent098.034Abducent119.825Facial098.036Glossopharngeal1614.297Vagus032.678Hypoglossal098.03Total = ( 112 )6558.03

  • DISTAL METASTASIS96%296%2%1%1%96%

  • INVESTIGATIONS1- RADIOLOGY -X-ray soft tissue lateral view of the neck. - CT scan nasophynx - MRI


    4. BODY SCAN

  • World Health Organization (WHO) classifies

    NPC into 3 types according to histology.

  • Keratinizing squamous cell carcinoma is WHO type 1. Non keratinizing carcinoma is WHO type 2. Undifferentiated carcinomas and lymphoepithelioma are WHO type 3.

  • Risk factors in endemic areasEBV-association is reported to be strongly associated with types 2 and 33, 4. Risk factors in endemic areas include :i.EBV,ii salty diet, iii. volatile nitro,iii. HLA antigen haplotype9.

  • However, in non-endemic regions disease

    is associated with alcohol and tobacco use9

  • Stage: Locally advanced and metastatic diseasewas observed in 85.4% of patients.Locally advanced disease includes all cases with any cranial nerve palsy, cervical lymphadenopathy or T4 lesions. Common sites for metastasis were bone, lung and Liver.

  • SUMMARY NPC is common in Sudanese population and tends to affect younger age group with male predominance. Most cases present with nodal involvement (CLN)or locally advanced disease. Patients had similar features of histology seen in endemic regions with predominance of WHO-3 histology type

  • References:1

    Cathryn E. Tune, Per-Gunnar Liavaag, Jeremy L. Freeman, et al. Nasopharyngeal Brush Biopsies and Detection of Nasopharyngeal Cancer in a High-Risk Population. J Natl Cancer Inst; 1999; 91: 796800.Collins SL. Squamous cell carcinoma of the oral cavity and oropharynx. In: Ballenger JJ, Snow JB Jr., eds. Otorhinolaryngology: head and neck surgery.15th ed. Media, Pa.: Williams & Wilkins, 1996:249-368.Vasef MA, Ferlito A, Weiss LM. Nasopharyngeal carcinoma, with emphasis on its relationship to Epstein-Barr virus. Ann Otol Rhinol Laryngol; 1997;106: 348-56.Cheng Her. Nasopharayngeal cancer and the Southeast Asian patient. Am Fam Physician; 2001; 63 (9): 1776-1782.Levine PH, Pocinki AG, Madigan P, Bale S. Familial nasopharyngeal carcinoma in patients who are not Chinese. Cancer; 1992; 70:10249.Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer. 1998; 77:228-35.Vokes EE, Weichselbaum RR, and Lippman SM, Hong WK. Head and neck cancer. New Eng J Med; 1993; 328:184-194.Hirayama, T. Descriptive and analytical epidemiology of nasopharyngeal cancer. In: Nasopharyngeal Carcinoma: Etiology and Control. Eds. G. de The and Y, Ito. IARC Scientific Pub 20: p167, 1978.Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet 1997;350: 108791.Farrell PJ, Cludts I, Stuhler A. Epstein-Barr virus genes and cancer cells. Biomed Pharmacology; 1997; 51:25867.Gasim J, Bachouchi M, Cvitkovic E, et al. Nasopharangeal carcinoma: medical oncology view point: the Gustave Roussy experience. Ann oncol; 1990; 1: 245-253. (Cross ref) (Medline).Neel HB 3d. Nasopharyngeal carcinoma: diagnosis, staging, and management. Oncology (Huntingt); 1992; 6:8795.Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys; 1992; 23:27180.Altun M, Fandi A, Dupuis O, Cvitkovic E, Krajina Z, Eschwege F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 1995; 32:859-877.Hamad H. M. A. cancer initiative in Sudan. Annals of oncology; 2006; 17 (supplement 8): viii33-viii38.Hidayatalla A, Malik M.O.A, El Hadi A. E, Osman A. A, Hutt M. S. R. studies on nasopharyngeal carcinoma in the Sudan: Epidemiology and aetiology. Eur J cancer clin oncol; 1983; 16 (6): 705-710.Bing-Jian Feng , Majida Jalbout , Wided Ben Ayoub , et al. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Inter J cancer; 2007; 121 (7): 1550-1555.Cancer incidence in Denmark 1996. Copenhagen: Danish National Board of Health, 1999.Ho, J. H. Epidemiology of nasopharyngeal carcinoma. In: Cancer in Asia. Ed. T. Hirayama. Baltimore University press; 1976: Page 49.Kumar S, Zinyu R, Singh I.K.K, Medhi S. B, Baruah T, Das B, Dutta L P. Studies on naspharyngeal carcinoma with reference to the North East region of India. Ann Natl Acad Med Sci (India); 1996; 32:199.Commoun M, Hoerner G. V, Mourali N. Tumor of nasopharynx in Tunisia: And anatomic and clinical study based on 143 cases. Cancer; 1974; 33:184.Umpati prasal, Lekhraj Rampal. Descriptive epidemiology of nasopharyngeal carcinoma in Peninsula Malaysia. Cancer causes and control; 1992; 3(2): 179-182.Marks JE, Phillips JL, Menck HR. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer; 1998; 83: 582-88.Burt RD, Vaughan TL, Mcknight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Inetr J cancer; 1992; 52: 549-56.Ho, J. H. AN epidemiology and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys; 1978; 4:189.

  • References:2

    Lin JC, Chen K Y, Wang CW, Jan JS, Liang WM, Tsai CS, Wei YH. Detection of Epstein - Barr virus DNA in the peripheral-Blood cells of patients with nasopharyngeal carcinoma: Relation to distant metastasis and survival. J of Clin Oncol; 2001; 19: 2607-2615.Chang YS, Tyan YS, Liu ST, et al: Detection of Epstein-Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. J Clin Microbiol; 1990; 28: 2398-2402.Mann RB, Epstein JI, et al: Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol; 1991; 138: 1461-1469.Chen CL, Wen WN, Chen JY, et al: Detection of Epstein-Barr virus genome in nasopharyngeal carcinoma by in situ DNA hybridization. Intervirology; 1993; 36: 91-98.Pathmanathan R, Prasad U, Chandrika G, et al: Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx: Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol; 1995; 146: 1355-1367. Jun Ma, Hai-Qiang Mai, Ming-Huang Hong, Hua-Qing Min, Zhi-Da Mao, Nian-Ji Cui, Tai-Xiang Lu, and Hao-Yuan Mo. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J of Clinl oncol; 2001; 19 (5): 1350-57.Min HQ. Nasopharyngeal carcinoma, in Gun GU (ed): Epidemiology: Beijing, China, People's medical press; 1996: 280-285.Geara FB, Nasr E, Tucker S L, Birihi E, Zaytoun G, Hadi U, Salem Z, El Saghir N, Issa PH, Shamseddine A. Nasopharyngeal cancer in MiddleEast: Experience of the American University of Beirut medical centre. Int. J. Radiation oncology Biol. Phys; 2005; 65: 1408-15. Dodge J L, Mills P K, Yang R C. Nasopharyngeal cancer in California Hmong, 1988-2000. Oral Oncology; 2005; 41: 596-601.Burt RD, Vaughan TL, Mcknight B. Descriptive epidemiology and survival analysis of nasopharyngeal carcinoma in the United States. Inetr J cancer; 1992; 52: 549-56.Lee A W N, Foo W, Mang O, Sze W.M, Chappell R, Lau W.H, Ko W.M. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20 -year period ( 1980-1999): An encouraging results in both incidence and mortality. Inter J cancer; 2002; 103; 5: 680-685.Chua D. T. T., Jonathan S. T. Sham, Damon Choy, Virchan Lorvidhaya, Yupa Sumitsawan, Sumitra Thongprasert, Visoot Vootiprux, Arkom Cheirsilpa, Tahir Azhar, Ary H. Reksodiputro. Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer; 1998; 83: 2270-2283.Marks JE, Phillips JL, Menck HR. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer; 1998; 83: 582-88.Marks JE, Phillips JL, R. Menck HR. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer; 1998; 83 (3):582-588.Ayan I, Altun M. Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Inter J Radiat Oncol Biol Phys; 1996; 35: 485-92.Barnes L, Brandwein M, Som PM. Diseases of the nasal cavity, paranasal sinuses, and nasopharynx. In: Barnes L, ed. Barnes Surgical Pathology of the Head and Neck. 2nd ed. New York: Marcel Dekker, Inc; 2000.Mertens R, et al. Treatment of nasopharyngeal carcinoma in children and adolescents. Cancer; 2005; 104: 1083-1089.Catherine K, Wang CC. Prognostic value of Chine race in nasopharyngeal cancer. Int J radiation oncology Biol Phys; 2002; 54: 752-58.Buddy YK. Wong. Nasopharyngeal carcinoma in Hong Kong- clinical features and diagnosis. Journal of Hong Kong medical association; 1987; 242-244.